76014-902 : Bloxiverz .5 mg/ml Intravenous Injection
NDC: | 76014-902 |
Labeler: | Eclat Pharmaceuticals, LLC |
Product Type: | Human Prescription Drug |
Drug Name: | Bloxiverz |
Dosage Form: | Intravenous Injection |
Application #: | NDA204078 |
Rev. Date: |
NDC Package Codes:
- 76014-902-10: 10 CARTON IN 1 PACKAGE (76014‑902‑10) > 1 VIAL, MULTI‑DOSE IN 1 CARTON (76014‑902‑33) > 10 ML IN 1 VIAL, MULTI‑DOSE
Active Ingredients:
- Neostigmine Methylsulfate
Dosage Strength:
- .5 mg/mL
Pharmaceutical Classes:
- Cholinesterase Inhibitor [EPC]
- Cholinesterase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 76014-002 Bloxiverz .5 mg/ml Intravenous Injection by Eclat Pharmaceuticals, LLC
- 76014-003 Bloxiverz 1 mg/ml Intravenous Injection by Eclat Pharmaceuticals, LLC
- 76014-903 Bloxiverz 1 mg/ml Intravenous Injection by Eclat Pharmaceuticals, LLC
- 51754-1200 Bloxiverz 1 mg/ml Intravenous Injection by Exela Pharma Sciences, LLC
- 51754-1210 Bloxiverz .5 mg/ml Intravenous Injection by Exela Pharma Sciences, LLC
- 51754-1220 Bloxiverz 1 mg/ml Intravenous Injection by Exela Pharma Sciences, LLC
- 51754-1240 Bloxiverz 1 mg/ml Intravenous Injection by Exela Pharma Sciences, LLC
- 68001-329 Bloxiverz 1 mg/ml Intravenous Injection by Bluepoint Laboratories
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 76014-006Next: 76014-903 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.